Views & Analysis Nontuberculous mycobacteria – an emerging public health prob... The challenge of treating Nontuberculous mycobacteria.
Oncology Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.
